DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,462 | -2.5% | 941 | -5.7% | 0.21% | -4.5% |
| Q2 2023 | $239,520 | -4.8% | 998 | 0.0% | 0.22% | -7.9% |
| Q1 2023 | $251,536 | -5.1% | 998 | 0.0% | 0.24% | -5.1% |
| Q4 2022 | $265,000 | +2.7% | 998 | 0.0% | 0.25% | -5.9% |
| Q3 2022 | $258,000 | +2.0% | 998 | 0.0% | 0.27% | +7.2% |
| Q2 2022 | $253,000 | -13.7% | 998 | 0.0% | 0.25% | +3.3% |
| Q1 2022 | $293,000 | -10.7% | 998 | 0.0% | 0.24% | -12.9% |
| Q4 2021 | $328,000 | +7.9% | 998 | 0.0% | 0.28% | +6.1% |
| Q3 2021 | $304,000 | +11.4% | 998 | -2.0% | 0.26% | +11.0% |
| Q2 2021 | $273,000 | +18.7% | 1,018 | -0.4% | 0.24% | +11.8% |
| Q1 2021 | $230,000 | 0.0% | 1,022 | -1.2% | 0.21% | -15.2% |
| Q4 2020 | $230,000 | -5.7% | 1,034 | -8.9% | 0.25% | -17.5% |
| Q3 2020 | $244,000 | +7.0% | 1,135 | -11.9% | 0.30% | -1.3% |
| Q2 2020 | $228,000 | +2.7% | 1,289 | -10.9% | 0.31% | +24.3% |
| Q4 2019 | $222,000 | +6.2% | 1,447 | 0.0% | 0.25% | -2.4% |
| Q3 2019 | $209,000 | -3.2% | 1,447 | -4.4% | 0.25% | -0.8% |
| Q2 2019 | $216,000 | -4.4% | 1,514 | -11.5% | 0.26% | -5.2% |
| Q1 2019 | $226,000 | +11.3% | 1,711 | -27.6% | 0.27% | +32.5% |
| Q4 2014 | $203,000 | – | 2,363 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |